In addition, studies have shown that the PTPRC SNP (rs10919563) was associated with an excellent response to anti-TNF-α therapy in patients with RA (36), and the rs7195994 variant at the FTO locus has been related to a clinical response with infliximab (44). Here, TNF is linked to rheumatoid arthritis.